JBC Avanti Polar Lipids

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M110178200 on March 6, 2002

J. Biol. Chem., Vol. 277, Issue 20, 17630-17637, May 17, 2002
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
277/20/17630    most recent
M110178200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Stapleton, M. R.
Right arrow Articles by Green, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Stapleton, M. R.
Right arrow Articles by Green, J.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Interaction of the Salmonella typhimurium Transcription and Virulence Factor SlyA with Target DNA and Identification of Members of the SlyA Regulon*

Melanie R. StapletonDagger , Valia A. NorteDagger , Robert C. Read§, and Jeffrey GreenDagger

From Dagger  the Krebs Institute for Biomolecular Research, Department of Molecular Biology and Biotechnology, University of Sheffield, Western Bank, Sheffield S10 2TN, United Kingdom and the § Division of Genomic Medicine, University of Sheffield Medical School, Sheffield S10 2RX United Kingdom

Received for publication, October 23, 2001, and in revised form, March 5, 2002

    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

The SlyA protein from Salmonella typhimurium is a transcription factor that contributes to virulence. It is shown that a slyA mutant is attenuated in the presence of murine macrophages compared with the parent strain. Moreover, after growth in minimal medium, survival of the slyA mutant was reduced. Altered levels of flagellin (fliC), PagC, IroN, and outer membrane proteins suggest that the slyA mutation affects the surface properties of Salmonella. The isolated SlyA protein is a cofactor-free homodimer that recognizes five sites within the promoter region of the slyA gene. One of these sites contained a near perfect inverted repeat TTAGCAAGCTAA. The other four sites contained related sequences. Occupation of the SlyA sites in the slyA promoter prevented open-complex formation, consistent with the pattern of slyA::lacZ expression parental and slyA mutant strains. By combining the footprinting data with potential SlyA binding sites recovered from a pool of random DNA sequences, a consensus was defined and used to probe the NIH Salmonella unfinished genomes data base. These searches revealed the presence of consensus SlyA sites upstream of omp, ispA, xseB, slyA, and a gene encoding a protein with homology to a hemagglutinin. Accordingly, transcription of an omp::lacZ fusion was reduced in a slyA mutant. Given the difficulties in obtaining a comprehensive picture of intracellular gene expression, the definition of the DNA sequence recognized by a transcription factor (SlyA) that is essential for survival in the macrophage environment should allow a complete regulon of genes with altered expression upon exposure to macrophages to be determined once the S. typhimurium genome annotation is complete.

    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Salmonella serotypes can infect many animal species, causing a variety of disease states ranging from mild enteritis to severe systemic salmonellosis. The precise nature of the disease is governed by the specific combination of host and serotype. Although many genes have been shown to be involved in pathogenesis, their precise roles in the various stages of disease are often ill defined. However, it seems clear that appropriate regulation of gene expression is essential for a pathogen to adapt to a particular host environment.

The SlyA protein from Salmonella typhimurium is a member of the MarR family of transcription factors that are required for the adaptation of a variety of bacteria to different environments. The family includes: MarR and EmrR (Escherichia coli), which regulate genes involved in multiple antibiotic resistance; PecS (Erwinia chrysanthemi), which controls pectinase and cellulase production, facilitating the infection of fruit; HprR (Bacillus subtilis) required for hydrogen peroxide resistance and sporulation regulation; and RovA (Yersinia enterocolitica and Y. pseudotuberculosis) required for the regulation of invasin expression (1-3). Salmonella strains carrying slyA mutations are severely attenuated for virulence in mice by a variety of infection routes, including intragastric (4, 5). Furthermore, slyA mutants are unable to survive within the tissues of the reticuloendothelial system and are hypersensitive to the products of the respiratory burst, including hydrogen peroxide (6). Therefore it has been suggested that SlyA controls genes required for resistance to oxidative attack by the host and survival in macrophages (6).

Despite the apparently fundamental role that SlyA plays in overcoming host defenses, little is known about the properties of the SlyA protein and its mechanism of action. SlyA was originally thought to be a hemolytic virulence factor by virtue of its ability to confer a hemolytic phenotype on E. coli K12 (4). Subsequently it has been shown that E. coli possesses a gene (hlyE, also designated clyA, or sheA) encoding a novel hemolysin (7). Overproduction of S. typhimurium SlyA, Actinobacillus pleuropneumoniae FNR (HlyX), or E. coli MprA proteins activate expression of hlyE, thereby conferring a hemolytic phenotype on E. coli (8-11). Site-directed mutagenesis led to the suggestion that a GC-rich sequence located between an unusual heptameric -10 element (TATGAAT) and a conventional -35 element in the hlyE promoter might be the site of SlyA interaction and thereby mediate activation of hlyE transcription (12). Here, we report that a slyA mutant strain is impaired in associating with macrophages and in starvation survival. A SlyA binding site consensus is defined, and data base searching reveals potential members of the SlyA regulon.

    EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Bacterial Strains, Plasmids, and Microbiological Methods-- Relevant characteristics of the bacterial strains and plasmids used are given in Table I. Bacteria were grown in L broth (tryptone, 10 g liter-1; yeast extract 5 g liter-1; NaCl 5 g liter-1) at 37 °C unless otherwise stated. Media were supplemented with ampicillin (100 µg ml-1), tetracycline (5-10 µg ml-1), chloramphenicol (20 µg ml-1) and isopropyl-beta -D-thiogalactoside (IPTG, 100 µg ml-1) as appropriate. For beta -galactosidase activity measurements, aerobic cultures were grown in 250 ml conical flasks containing 5 ml of medium with shaking at 200 rpm Promoter activities were estimated by measuring beta -galactosidase production (all determinations were done in triplicate on at least two independent cultures) according to Miller (13).

For some phenotypic tests the slyA mutant and parental strains were grown aerobically at 37 °C in a defined medium: Tris-HCl (pH 7.2) (100 mM); K2SO4 (0.5 mM); KH2PO4 (1 mM); NaCl (5 mM); NH4Cl (5 mM); MgCl2 (10 mM); CaCl2 (0.1 mM); thiamine (1 mM); and glucose (10 mM). Samples from stationary phase cultures were removed at intervals up to 48 h, and serial dilutions were plated on L agar to estimate the numbers of colony-forming units after overnight incubation at 37 °C. To investigate the effect of the slyA mutation on secreted proteins bacteria were collected by centrifugation, and the culture supernatants were filtered through 0.2-µm filters before precipitating the secreted proteins with trichloroacetic acid (10%, w/v). The precipitated proteins were washed with acetone before being dissolved in SDS-PAGE loading buffer and separated by SDS-PAGE (12.5% gels). Outer membrane proteins were also analyzed by SDS-PAGE of outer membrane fractions prepared by sarkosyl NL30 (2% v/v) treatment of total membrane fractions. Proteins were visualized with Coomassie Brilliant Blue.

Standard methods for the manipulation of DNA were followed (14). The slyA coding region was amplified and isolated as a 600-bp product by PCR using S. typhimurium genomic DNA as the template and primers MS1 (TTTTGGATCCATGAAATTGGAATCGCCACTAGG) and MS2 (TTTTGTCGACCGGCAGGTCAGCGTGTCG) containing unique BamHI and SalI restriction sites (underlined) to facilitate cloning into the expression vector pGEX-KG (15). The resulting plasmid (pGS1482) was transformed into E. coli JM109 to create the overproducing strain JRG4385.

A fragment containing the slyA promoter was amplified and isolated as a 424-bp product by PCR, using S. typhimurium genomic DNA as the template and the primers VN7 (TTTTGAATTCAGAATGGCGGAAAGTAAACAGATG) and VN8 (TTTTGGATCCTTGATGAATATTGTGCAACGTGAC) containing unique EcoRI and BamHI restriction sites (underlined) to facilitate cloning into plasmid pRW50. This plasmid is referred to as pGS1384. Alterations to the promoter sequence for footprinting and bandshift analyses were achieved by PCR using appropriate pairs of mutagenic primers.

A pBR322 derivative containing the slyA promoter and coding region on an ~750-bp EcoRI-BamHI fragment amplified from S. typhimurium genomic DNA using primers S583 (TTTTGAATTCAATGCTTTAGTTTTAGCC) and S584 (TTTTGGATCCCGGCAGGTCAGCGTG) was constructed. Automated DNA sequencing was used to confirm the sequence of the amplified products.

Macrophage Experiments-- The murine macrophage-like cell line J774 was used to investigate the effects of a slyA lesion on the interaction between S. typhimurium and macrophages. The J774 cells were grown in Dulbecco's minimal essential medium (DMEM)1 containing 10% (v/v) fetal calf serum, and 1 × 105 cells were seeded onto glass coverslips in 24-well tissue culture plates and incubated for 16 h at 37 °C in the presence of 5% CO2. The medium was removed from the wells, and the coverslips were washed twice in DMEM before adding 0.5 ml of fresh DMEM plus 10% fetal calf serum and 4% bovine serum albumin to the wells. The plates were then incubated for a further 30 min in the presence of 5% CO2. The S. typhimurium strain ST12/75 and the isogenic slyA mutant (Table I) were grown aerobically in nutrient broth for 16 h. These cultures were used as 1% (v/v) inocula for fresh nutrient broth and grown without shaking at 37 °C in the presence of 5% CO2 to A600 nm ~0.6. The bacteria were harvested, resuspended in DMEM plus 10% (v/v) BALB/c mouse serum (Harlan Sera-Lab), and incubated at 37 °C for 30 min in the presence of 5% CO2. The bacteria were washed in PBS, resuspended in DMEM, and vortexed with glass beads for 1 min to prevent clumping of the cells. The medium was removed from the macrophages and 1 × 107 bacteria in 200 µl of DMEM was added to the wells. The plates were incubated at 37 °C in the presence of 5% CO2 for up to 3 h. At 30-min intervals the bacterial suspension was removed, and the wells were washed twice with PBS. The cells were fixed with 2% paraformaldehyde at 37 °C in the presence of 5% CO2 for at least 15 min. The wells were then washed with PBS. Control wells were included, without S. typhimurium (DMEM only added) to check for contamination, and without macrophages (bacterial suspensions only) to check there was no significant binding of bacteria to the glass coverslips. The coverslips were irrigated with PBS containing 1:50 rabbit anti-Salmonella O antibody (Bacto) and incubated at 37 °C for 12 min. This was followed by 1:20 fluorescein isothiocyanate-conjugated goat anti-rabbit IgG (Sigma) plus 5% goat serum at 37 °C for 12 min. The wells were then washed with PBS. The macrophages and bacteria were counterstained with the nucleic acid stain DAPI (4,6-diamidino-2-phenylindole dihydrochloride) (Molecular Probes), diluted 1:2,500 in PBS, and incubated at room temperature in the dark for 15 min. The DAPI solution was removed, and the wells were washed with water. The coverslips were removed from the wells and air-dried. They were mounted onto microscope slides with Vectashield mounting fluid (Molecular Probes) and viewed at ×1000 magnification using a DMRB 1000 fluorescence microscope (Leica, Germany). The total number of DAPI-stained bacteria attached to macrophages was counted; internalization of bacteria was estimated by subtracting the numbers of extracellular bacteria (identified by co-localization with fluorescein isothiocyanate) from this number. Each experiment was carried out at least in triplicate.

                              
View this table:
[in this window]
[in a new window]
 
Table I
Bacterial strains and plasmids used in this study

GST-SlyA Overexpression and Purification-- SlyA was amplified as a GST-SlyA fusion in JRG4385. Aerobic cultures were grown at 25 °C to A600 0.6 at which point expression was induced by the addition of IPTG (100 µg ml-1). Incubation was continued for a further 3 h when the bacteria were collected by centrifugation and used immediately or stored at -20 °C.

Clarified cell-free extracts were produced by resuspending the bacteria in 5 mM Tris-HCl (pH 8.0) containing 150 mM NaCl, 2.5 mM CaCl2 and 0.1% (v/v) 2-mercaptoethanol, and lysing the cells by two passages through a French pressure cell, followed by centrifugation. The GST-SlyA fusion protein was adsorbed onto a column (1 ml liter-1 culture) of GSH-Sepharose (Amersham Biosciences) equilibrated with the resuspension buffer. The SlyA protein was released from the fusion by incubating the column overnight with 5 units of thrombin (Sigma) and eluting the protein in resuspension buffer.

Protein Analysis-- Protein concentration was estimated using the Bio-Rad protein assay using bovine serum albumin as standard. Protein purity was assessed by SDS-PAGE and staining with Coomassie Brilliant Blue. The oligomeric state of SlyA was determined by native polyacrylamide gels (4, 4.5, 5, 5.5, 6, 7, 8, and 9%) containing Tris-HCl (pH 8.3), with protein standards of carbonic anhydrase (29,000), beta -lactoglobulin (35,000), aldolase (160,000), catalase (240,000), and thyroglobulin (670,000), and by gel filtration using a calibrated Sephacryl S-100 HR column (standards: aprotinin, 6,500; RNase A, 13,700; chymotrypsinogen, 25,000; bovine serum albumin, 66,000; blue dextran, 2,000,000) equilibrated with 5 mM Tris-HCl (pH 8.0), 150 mM NaCl, 2.5 mM CaCl2, and 0.1% (v/v) 2-mercaptoethanol. The optical spectrum of SlyA was obtained using a Unicam UV-4 spectrophotometer. The iron content of the protein was determined by denaturing samples of SlyA with 1% (w/v) trichloroacetic acid and boiling to release protein-bound iron. After centrifugation to remove precipitated protein, saturated sodium acetate (0.4 ml in a final assay volume of 1 ml), sodium ascorbate (2% w/v) and bathophenanthroline (0.2% w/v) were added. The amount of iron in the samples was calculated by measuring the absorbance at 535 nm and comparing the values obtained to a standard curve constructed with serial dilutions of ferrous ammonium sulfate solutions. The total metal ion content of the SlyA protein was estimated by ICP-MS on samples of freeze-dried protein dissolved in water. The metal ion content of the solvent was also determined. The SlyA N-terminal amino acid sequence was obtained using standard technology with an Applied Biosystems protein sequencer.

Bandshift Assays-- The slyA promoter region (PslyA) was amplified by PCR using plasmid pGS1384 as the template and primers VN7 and VN8. The resulting products were cut with restriction enzyme BamHI, allowing 3' radiolabeling of the top strand by Klenow enzyme and [alpha -32P]dGTP.

DNA binding in vitro was tested by bandshift analyses on 6% non-denaturing TBE-buffered polyacrylamide gels, using radiolabeled PslyA DNA fragments. Approximately 10 ng of DNA and 0.2-5.0 µM SlyA protein were co-incubated for 2 min at 25 °C in 10 mM Tris-HCl (pH 9.0), 50 mM KCl, and 0.1% (v/v) Triton X-100 (total incubation volume 10 µl), before loading onto the gel for autoradiographic analysis.

The effect of SlyA on the binding of RNA polymerase to PslyA in vitro was tested by bandshift analyses on 5% non-denaturing TBE-buffered polyacrylamide gels, using 0.64 units of E. coli RNA polymerase (Amersham Biosciences) and/or 1.2 µM SlyA as appropriate. The various combinations of proteins were incubated with ~10 ng of radiolabeled DNA for 2 min at 25 °C in 10 mM Tris-HCl (pH 9.0), 50 mM KCl, and 0.1% (v/v) Triton X-100 (total incubation volume 10 µl). Where appropriate the resulting complex was then challenged with heparin (0.1 mg ml-1) for 2 min at 25 °C before loading onto the gel for autoradiographic analysis.

DNase I Footprinting-- The reactions (total volume 10 µl) contained radiolabeled PslyA (~10 ng), SlyA (2.0 and 4.0 µM), 20 mM Tris-HCl (pH 8.0), 10 mM MgCl2, 10 mM dithiothreitol, and 5% (v/v) glycerol. The mixtures were incubated for 2 min at 25 °C, followed by digestion with DNase I (1 µl of 1 unit µl-1 for 15-60 s at 25 °C). Reactions were stopped by addition of 200 µl of 0.3 M sodium acetate (pH 5.2) containing 20 mM EDTA followed by phenol/chloroform extraction. The DNA was ethanol-precipitated and resuspended in 10 µl of loading buffer (80% v/v formamide, 0.1% w/v SDS, 10% v/v glycerol, 8 mM EDTA, 0.1% w/v bromophenol blue, 0.1% w/v xylene cyanol) for electrophoretic fractionation on 6% polyacrylamide-urea gels and autoradiographic analysis. Maxam and Gilbert G tracks of the DNA fragments were used to provide a calibration (16).

Permanganate Footprinting-- The reactions (total volume 20 µl) contained PslyA (~20 ng), 10 mM Tris-HCl (pH 9.0), 50 mM KCl, 0.1% (v/v) Triton X-100, SlyA (1.2 µM), and/or RNA polymerase (1.28 units) as appropriate. The mixtures were incubated at 25 °C for 30 min, and then where indicated the resulting complexes were challenged with heparin (0.1 mg ml-1) for 2 min before the addition of 1 µl of 200 mM KMnO4. The mixtures were incubated for a further 4 min at 25 °C. The reactions were stopped with 50 µl of 0.3 M sodium acetate (pH 5.2) containing 20 mM EDTA and 1.5 M 2-mercaptoethanol, followed by phenol/chloroform extraction. The DNA was ethanol-precipitated and resuspended in 10 µl of loading buffer (see above) for electrophoretic fractionation on 6% polyacrylamide-urea gels and autoradiographic analysis.

Transcript Mapping-- The transcription start point of PslyA was determined by RNA extraction (17) and primer extension. Total RNA was prepared from stationary phase (24 h) S. typhimurium pGS1384 grown aerobically in L broth. For primer extension the method of Gerischer and Durre (18) was used with 100 µg of RNA and avian myeloblastosis virus reverse transcriptase (40 units) (Transgenomic). After ethanol precipitation the cDNA was fractionated on 6% urea-polyacrylamide gels for autoradiographic analysis. The gels were calibrated using Maxam and Gilbert G tracks of PslyA and PFF(-41.5) (16).

Selection of the SlyA Binding Site from Random DNA Sequences-- The method was based on the SELEX procedure. The following oligonucleotides were synthesized: A, 5'-TGACGAATTCACGTGN20GTACGGATCCATGCG-3', where N indicates that either G, A, T, or C was inserted at that position; B, 5'-TGACGAATTCACGTG-3'; C, 5'-CGCATGGATCCGTAC-3'. Double-stranded DNA was generated by PCR with 1 µM oligonucleotide A as a template and 5 µM each oligonucleotides B and C as primers in 10 mM Tris-HCl (pH 9.0), 50 mM KCl, 0.1% (v/v) Triton X-100, 1 mM MgCl2, 0.5 mM dNTPs, and 5 units of Taq polymerase. The reaction mixture was heated at 94 °C for 2 min, then for each of 12 cycles was denatured at 92 °C for 1 min, annealed at 46 °C for 1 min, and extended at 72 °C for 1 min. A sample (2 µl) of the resulting mixture was used as a template for a further amplification, and the two reactions were pooled.

E. coli strain JRG4385 was grown aerobically at 25 °C to A600 nm ~0.6. Expression of GST-SlyA was induced by the addition of 100 µg ml-1 IPTG, and the cultures were incubated for a further 3 h. The bacteria were collected, resuspended in 5 mM Tris-HCl (pH 8.0) containing 150 mM NaCl, 2.5 mM CaCl2, and 0.1% (v/v) 2-mercaptoethanol, and lysed by two passages through a French pressure cell. The extract was then clarified by centrifugation. Crude extract containing GST-SlyA was then mixed with 0.1 ml GSH-Sepharose (Amersham Biosciences). A column was made with 50 µl of the mixture, which was washed with 5 column volumes of binding buffer (10 mM Tris-HCl (pH 9.0), 50 mM KCl, 0.1% v/v Triton X-100). The pooled PCR products were passed through the column followed by washing with 5 column volumes of binding buffer. Bound DNA was eluted with 1 column volume of M sodium acetate, and ethanol precipitated. The DNA was resuspended in 10 mM Tris-HCl (pH 8.5) and used as the template for five more PCRs (using oligonucleotides B and C as primers), which were pooled and used for further rounds of selection on GST-SlyA columns. After a total of three rounds of selection and amplification, the eluted DNA was cloned into pGEM-T Easy Vector System I (Promega). After transformation into E. coli strain JM109, the plasmids were recovered, and the cloned regions were sequenced and analyzed. The same protocol was used with columns prepared with glutathione-S-transferase (GST) only to ensure that the DNA recovered was interacting specifically with SlyA and not GST or the column matrix.

    RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Phenotypic Characterization of a slyA Mutant-- It has been reported that slyA mutants are unable to survive within the tissues of the reticuloendothelial system and are hypersensitive to the products of the respiratory burst including hydrogen peroxide (6). Therefore, the interaction of parental and slyA mutant strains of S. typhimurium with J774 macrophages was measured. After 30 min of incubation, approximately equivalent numbers of wild type and mutant organisms were associated with the surface of macrophages, but thereafter, over a 2.5-h chase, the numbers of wild type organisms associated with cells increased (Fig. 1a). In contrast, the slyA mutant strain exhibited no such increase. The difference was greatest after 180 min, when on average ~4-fold more bacteria were associated with each macrophage for the parent strain compared with the slyA mutant. The proportion of bound bacteria that were internalized at any point during the chase was similar for the parent and slyA mutant strains, with ~60% internalization after 30 min and ~78% internalization after 180 min (Fig. 1b). Therefore SlyA may be acting by conferring resistance to extracellular killing or by facilitating adherence to macrophage receptors that transduce a benign intracellular course.


View larger version (17K):
[in this window]
[in a new window]
 
Fig. 1.   Interaction of S. typhimurium parental (ST12/75) (black-diamond ) and slyA (black-square) strains with J774 macrophages at 37 °C. a, estimation of the numbers of bacteria associated (those adhered and internalized) with macrophages. b, estimation of the percentage of total bacteria internalized by macrophages after co-incubation for the indicated times. The values are expressed as numbers of bacteria per macrophage determined in at least three experiments with standard error bars shown.

Because slyA expression is maximal in stationary phase (6) the effect of the slyA lesion on stationary phase survival of S. typhimurium was investigated in a defined Tris-minimal medium. The aerobic growth kinetics of the parent and mutant were similar (not shown). However, survival of the slyA strain, as judged by the number of colony-forming units remaining over a 48-h period, was dramatically reduced compared with the parent (Fig. 2a). Investigation of the amount of protein present in culture supernatants of the parent and slyA strain grown in the Tris-minimal medium revealed that the amount of flagellin (FliC), (identified by N-terminal amino acid analysis, AQVINTNSLSL) produced by the slyA mutant was much reduced compared with the parental strain (Fig. 2b). This observation is consistent with the slyA mutant phenotype of reduced survival within macrophages (6) because previous studies have indicated that a fliD (encodes a flagellar hook protein) mutant has diminished capacity to survive within macrophages (19, 20). Further investigation revealed altered levels of outer membrane proteins including OmpC, OmpF, OmpA, PagC (a protein known to be required for full virulence and survival in macrophages), and IroN (a TonB-dependent outer membrane siderophore receptor) when the parent was compared with the slyA mutant (Fig. 2b). In the presence of SlyA the amount of truncated OmpA (Mr ~30,000, cf. full-length OmpA 35,000) was greater than in the absence of SlyA, suggesting that SlyA may influence the processing of this protein (Fig. 2b). Mass spectrometry suggested that the ratio of OmpC:OmpF was greater for the parent than for the mutant. Moreover, the slyA mutant possessed reduced amounts of IroN, but the level of PagC was increased (Fig. 2b). These two proteins are both associated with virulence and survival within macrophages, providing a direct link with the slyA phenotype. These data suggest that slyA is important for survival of Salmonella in the stationary phase, consistent with previous observations that slyA expression is enhanced in stationary phase cultures (6), that SlyA can act both as a repressor and activator of transcription, and that the slyA lesion affects the surface and virulence properties of the bacteria.


View larger version (17K):
[in this window]
[in a new window]
 
Fig. 2.   Loss of viability of a S. typhimurium slyA strain in Tris-minimal medium. a, the parent (ST12/75, black-square) and slyA (ST12/75Delta slyA, ) strains were grown in Tris-minimal medium to stationary phase. Samples were taken from the cultures at the indicated times, and the viability of the bacteria was determined by estimating the number of colony-forming units present by plating serial dilutions on L agar. The error bars indicate the standard deviations from the average of three experiments. b, secreted and outer membrane proteins of aerobic exponential phase cultures of the parent and slyA mutant grown in Tris-minimal medium. SDS-PAGE fractionation of secreted proteins from ST12/75Delta slyA (lane 1), ST12/75 (lane 2), outer membrane proteins from cultures of ST12/75 (lane 3), ST12/75Delta slyA (lane 4). The positions of flagellin (FliC), OmpC, OmpA, (and a truncated OmpA, OmpA'), IroN, and PagC are indicated.

Overproduction of SlyA in E. coli and Properties of the Isolated Protein-- To further characterize the SlyA protein it was overproduced in E. coli (JRG4385) as a GST fusion protein. After induction by IPTG (100 µg ml-1 IPTG at 25 °C), the overproduced GST-SlyA fusion protein represented 7% of total bacterial protein and 9% of soluble cell protein. On column cleavage of GST-SlyA with thrombin yielded 9 mg of pure SlyA per liter of culture (Fig. 3). The final product was judged to be 80% pure by SDS-PAGE with two contaminating polypeptides. The major species was shown to be SlyA by N-terminal amino acid sequencing (GSMKLESPLG). The additional N-terminal amino acids, GS, derive from the linker that contains the thrombin cleavage site of pGEX-KG. Recently it has been suggested that the SlyA protein may initiate not at an ATG codon but at a TTG codon (21), in which case the SlyA protein used here has four additional N-terminal amino acids (GSMK) compared with the native protein. As reported for many other proteins expressed as GST fusions, the two contaminating polypeptides that co-purified with SlyA were shown by N-terminal amino acid sequencing (GSMKLE) to be prematurely terminated SlyA fragments.


View larger version (47K):
[in this window]
[in a new window]
 
Fig. 3.   SDS-PAGE analysis of over-produced SlyA. Lane 1, molecular mass markers (sizes in kDa are indicated); lane 2, crude extract (20 µg); lane 3, SlyA (10 µg).

Analysis of the oligomeric state of the purified protein revealed that SlyA is a homodimer, with a Mr of 14,000 by SDS-PAGE, 31,600 by gel filtration, and 33,000 by native polyacrylamide gel electrophoresis. The mass of SlyA as determined by mass spectrometry (16,904 Da) was 57 Da greater than the predicted value of 16,847 Da based on the nucleotide sequence of the cloned slyA gene. The additional mass may represent a posttranslational modification of the SlyA protein, but 57 Da does not correspond to the mass of any of the common protein modifications. The mass discrepancy could be explained by the presence of one iron atom per SlyA monomer, but chemical analysis using bathophenanthroline as an iron chelator indicated that the isolated protein was iron-free. Total metal ion analysis by ICP-MS confirmed the absence of iron (<= 0.03 atoms per monomer) and revealed that no other metals, with the exception of Na+ (70 atoms per monomer) and Ca2+ (4.7 atoms per monomer) were present in the isolated protein samples. Thus, it is perhaps more likely that the additional mass is due to retention of one Na+ and one Cl- (total mass 58.44 Da) adduct from the purification buffer, which contains 150 mM NaCl and 2.5 mM CaCl2. The optical spectrum of the protein was featureless except for an absorbance maximum at 280 nm, indicating the absence of any chromogenic cofactors.

Interaction of SlyA with the S. typhimurium slyA Promoter Region-- Many transcription factors autoregulate their own expression, and therefore interaction of the SlyA protein with the promoter of the S. typhimurium slyA gene (PslyA) was investigated. Bandshift assays with a PCR-generated 424-base pair fragment that extended 287 base pairs upstream of the slyA TTG codon (21) indicated that SlyA could interact with PslyA and that as the concentration of SlyA was increased at least three PslyA-SlyA complexes could be discerned (Fig. 4). The apparent Kd (concentration of SlyA required to retard 50% of PslyA present) was ~0.4 µM.


View larger version (41K):
[in this window]
[in a new window]
 
Fig. 4.   Interaction of SlyA with the PslyA promoter. SlyA retards the mobility of the SlyA promoter in a band shift assay: lane 1, no protein; lane 2, 0.2 µM; lane 3, 0.4 µM; lane 4, 0.8 µM; lane 5, 1.2 µM; lane 6, 1.6 µM; lane 7, 2.0 µM; lane 8, 3.0 µM; lane 9, 4.0 µM; and lane 10, 5.0 µM. The positions of the free DNA (F) and three SlyA-DNA complexes are indicated.

To test the effects of SlyA on RNA polymerase (RNAP) binding at PslyA, the SlyA protein and RNAP, both individually and in combination, were used in bandshift assays. These experiments revealed that RNAP could recognize PslyA and that adding SlyA did not alter the mobility of the retarded complex (Fig. 5a). When challenged with heparin, a stable PslyA-RNAP complex was observed indicating that RNAP alone is sufficient to generate an open complex at PslyA. However, in the presence of SlyA this heparin-stable complex failed to form and was replaced by a heparin-stable PslyA-SlyA complex (Fig. 5a, lanes 5-8). Thus it would appear that SlyA prevents open complex formation at PslyA and thus negatively regulates its own expression.


View larger version (25K):
[in this window]
[in a new window]
 
Fig. 5.   SlyA prevents open complex formation at PslyA. a, bandshift assays with PslyA with SlyA (1.2 µM) and RNA polymerase (0.64 units); lane 1, no protein; lane 2, no protein or heparin (0.1 mg ml-1); lane 3, RNA polymerase; lane 4, RNA polymerase and heparin; lane 5, SlyA; lane 6, SlyA and heparin; lane 7, SlyA and RNA polymerase; lane 8, SlyA, RNA polymerase and heparin. The positions of the free DNA (F) and the stable protein-DNA complex are indicated (RNAP, RNA polymerase; RNAP* denotes heparin-stable PslyA-RNAP complex; SlyA*, denotes heparin-stable PslyA-SlyA complex). b, primer extension analysis with RNA extracted from S. typhimurium pGS1384 and the primer VN8. Lane 1, PslyA G track; lane 2, PFF (-41.5) from pGS422 (Table II) G track; lane 3, primer extension product from the slyA gene. c, permanganate footprint at PslyA with SlyA (1.2 µM) and RNA polymerase (1.28 units); lane 1, no protein; lane 2, no protein and heparin; lane 3, RNA polymerase; lane 4, RNA polymerase and heparin; lane 5, SlyA; lane 6, SlyA and heparin; lane 7, SlyA, and RNA polymerase; lane 8, SlyA, RNA polymerase and heparin; lane 9, Maxam and Gilbert G track. Permanganate sensitive bases are indicated.

To place the SlyA binding sites at PslyA into context it was necessary to attempt to establish the slyA transcription start point. Primer extension analysis with RNA from stationary phase cultures of S. typhimurium suggested that slyA transcription initiated at 41 bases upstream of the translation start (Fig. 5b). Three bases further upstream there is a potential -10 element (TATTCT) separated by 17 bases from a potential -35 element (TTGAGA), thus the slyA transcription start point mapped here is located in an appropriate context.

The position of the transcript start and the inhibitory effects of SlyA on open complex formation at PslyA were confirmed using permanganate footprinting studies, which revealed that T bases at positions -6 and -7 in the predicted -10 element were sensitive to permanganate in the absence, but not in the presence, of SlyA (Fig. 5c). These data also indicate that the -10 element has been correctly predicted from the transcript start.

The regions of PslyA that interact with SlyA were determined by DNase I footprinting analysis (Fig. 6a, lanes 1-4). In the absence of heparin, a large region of protection was observed extending from +46 to -97 of PslyA, consistent with the multiple complexes observed in the bandshift assays (Fig. 4). This protected region was reduced to only 25 base pairs (+5 to +30) in the presence of heparin, suggesting that the most stable PslyA:SlyA interactions are formed within this region. Inspection of the heparin-resistant protected DNA sequence revealed the presence of a near perfect inverted repeat consisting of two hexamers TTAGCAAGCTAA (designated site I). Thus, it was predicted that this sequence represents the SlyA binding site. The presence of four related sequences (sites II-V) within the extended SlyA protected region supported this prediction (Fig. 6b). Combining the five sequences within the SlyA protected region yielded a putative consensus site TTAGCAA(g/t)C(a/t)AA (Table II).


View larger version (41K):
[in this window]
[in a new window]
 
Fig. 6.   The SlyA binding sites in the S. typhimurium slyA promoter. a, DNase I footprint of SlyA at unaltered PslyA (lanes 1-4) and PslyA in which the heparin-resistant site I (TTAGCAAGCTAA) is replaced by a mutated site (TcAGtAAaCTgA) (lanes 5-8). Lane 1, no protein; lane 2, no protein and heparin (0.1 mg ml-1); lane 3 2.0 µM SlyA; lane 4, 2.0 µM SlyA and heparin (0.1 mg ml-1); lane 5, no protein; lane 6, no protein and heparin (0.1 mg ml-1); lane 7 2.0 µM SlyA; lane 8, 2.0 µM SlyA and heparin (0.1 mg ml-1); lane 9, Maxam-Gilbert G track for unaltered PslyA; lane 10, Maxam-Gilbert G track for mutated PslyA. The open box indicates the region of SlyA protection in the absence of heparin. The filled box indicates the heparin-resistant region (+5 to +30). b, nucleotide sequence of the slyA promoter. The limits of protection by SlyA in the DNase I footprint are indicated by -97 and +46. The probable -10 and -35 regions (underlined) and the transcript start point (arrowed) are indicated. Sequences in boldface are related to the inverted repeat within the heparin-resistant region (I, boxed) and are labeled I-V. c, the effects of mutagenesis of site I on interaction of SlyA with promoter DNA. Lanes 1, no protein; lane 2, 0.3 µM; lane 3, 0.6 µM; lane 4, 0.9 µM; lane 5, 1.2 µM; lane 6, 1.8 µM; lane 7, 2.2 µM; lane 8, 2.8 µM. Upper panel, unaltered PslyA; lower panel, PslyA with mutated SlyA site I (TTAGCAAGCTAAright-arrowTCAGTAAACTGA). The positions of the free DNA (F) and SlyA-DNA complexes (SlyA) are indicated.

                              
View this table:
[in this window]
[in a new window]
 
Table II
Sequences of SlyA binding sites
Analysis of 20 DNA sequences recovered from a pool of random DNA sequences that were found to interact with SlyA. The numbers indicate the frequency that a particular base was found in each position. Also shown are the sequences of the five SlyA sites in PslyA.

The role of the heparin-resistant site (site I) in establishing the extended PslyA:SlyA complex was investigated by site-directed mutagenesis. Altering this site from TTAGCAAGCTAA to TcAGtAAaCTgA (lowercase indicates a base change), while leaving the other sites unaltered, did not abolish SlyA binding at PslyA, but 2-fold higher levels of SlyA were required to begin to retard the mobility of the mutated promoter relative to the unaltered promoter in bandshift assays (Fig. 6c). Footprinting analysis revealed that the SlyA protein still recognized the mutated site (Fig. 6a, lane 7), but that occupation of this region was now abolished by the addition of heparin (Fig. 6a, lane 8). The alterations made to the sequence of site I did not affect the occupation of the other four sites within PslyA. These observations are consistent with the reduced affinity of SlyA for the altered promoter and the mobilities of the fully loaded wild type and mutated promoters in bandshift assays (Fig. 6c).

The in vitro data predicted that slyA expression should be negatively autoregulated. Therefore, PslyA::lacZ transcriptional fusion was constructed by ligating the same 424-bp EcoRI-HindIII fragment used for the in vitro studies described above into the low copy number lac reporter vector pRW50 (27), generating the reporter plasmid pGS1384. beta -galactosidase activity was measured in parental and slyA mutant strains. After 24 h of aerobic growth at 25 °C the parental (slyA+) strain yielded 2034 ± 95 Miller units, whereas the slyA mutant yielded 3332 ± 345 Miller units. Expression of slyA from its own promoter in multicopy (pGS slightly enhanced the observed repression such that 1627 ± 175 Miller units were recovered. The relatively low level of repression observed might suggest that under the test conditions SlyA is mostly inactive. Alternatively, in vivo only the heparin-resistant SlyA site may be occupied, and from its location relative to RNAP only weak repression would be expected. Nonetheless, the simplest explanation for all of the observations described is that SlyA acts to repress its own expression by promoter occlusion.

Selection of the SlyA Binding Site from a Pool of Random DNA Sequences-- The footprinting data described above provided good indications of the sequence of the SlyA binding site, but to better define the site, a SELEX strategy for selecting targets from random DNA sequences was adopted. The approach used was to exploit the GST-SlyA fusion protein by fixing it on small (20-40 µl) GSH-Sepharose columns and passing through samples of DNA containing a 20-bp random sequence, flanked by regions of defined sequence as control columns loaded with GST alone were also used. After three cycles of DNA binding, elution and reamplification by PCR, the GST-SlyA-bound DNA was cloned into pGEM T-easy. The plasmids from 20 individual clones were isolated, and the relevant sections were sequenced. This procedure yielded 20 unique sequences, which were examined for common motifs. The results of the analysis are summarized in Table II, in which the frequencies of a particular nucleotide at each of the 12 positions corresponding to the heparin-resistant site in PslyA are provided. Only ligated vector was recovered from the control columns, indicating that the DNA sequences identified from the GST-SlyA columns were specific for SlyA. Thus the putative consensus sequence that emerged from this analysis ((t/g)T(g/a)GCAAGCTAA) was combined with the five sites from PslyA to yield a final consensus of TTAGCAAGCTAA.

    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

The SlyA protein of S. typhimurium is a member of a family of transcription factors related to MarR and associated with bacterial adaptation to stress (1, 2, 22). Here it is shown that the SlyA protein is a homodimer that recognizes a partially palindromic DNA sequence consisting of TTAGCAAGCTAA. The dimeric state of SlyA is consistent with recognition of a DNA target consisting of an inverted repeat. In this respect SlyA resembles the MarR protein, which is thought to adopt a dimeric state to recognize an inverted repeat composed of pentameric subelements (23), possibly through interaction with two putative helix-turn-helix motifs (24). Like the Hpr and MarR proteins, SlyA as isolated did not possess, or require, any co-factors to facilitate binding to target DNA suggesting that the intracellular content of SlyA is regulated and/or that a co-effector can interact with SlyA to abolish DNA binding. The nature of any SlyA co-effector is unknown, but the slyA mutant phenotype suggests that it may be associated with oxidative stress (6) and/or survival in macrophages. The pure SlyA protein now available should allow a range of possible signaling molecules to be tested for modulation of SlyA DNA binding in vitro.

The locations of the SlyA sites within PslyA were consistent with the observed autoregulation of slyA expression observed in vivo. The region occupied by SlyA covers the -10 and -35 promoter elements, thus by binding at these sites SlyA denies RNA polymerase access to the promoter, thereby repressing slyA expression. The size and location of the region of protection and the relatedness of the DNA sequences within the region indicated that at least five SlyA dimers bind at PslyA to repress slyA expression. The multiple PslyA-SlyA complexes observed in bandshifts and the abolition of open complex formation at PslyA in the presence of SlyA supported this conclusion. The latter experiments confirmed the location of the -10 element of PslyA, which had been predicted on the basis of sequence homology, and the position relative to the transcript start. The affinity of SlyA for each individual site within PslyA is likely to be different as indicated by the stepped appearance of the bandshift assays and by the formation of a heparin-resistant PslyA-SlyA complex. Site-directed mutagenesis of the heparin-resistant site indicated that it was not essential for SlyA to bind at PslyA but that the concentration of SlyA required to retard the mobility of PslyA DNA was greater for the altered promoter. This indicates that SlyA binds preferentially at the inverted repeat with a core TTAGC motif that constitutes site I.

The consensus SlyA binding site sequence (TTAGCAAGCTAA) defined here, was used to probe the Salmonella unfinished genomes data base (www.ncbi.nlm.nih.gov/Microb_blast/unfinishedgenome.html) to identify possible members of the SlyA regulon. These searches yielded 17 contigs from S. typhimurium LT2, Salmonella paratyphi, Salmonella enteritidis, and Salmonella dublin, which after further analysis were found to contain SlyA consensus sites upstream of slyA, ispA, and xseB, and genes encoding proteins with high similarities to OmpC (omp) and parainfluenza virus hemagglutinin, respectively. To test these predictions, a Pomp::lacZ fusion was created in pRW50, and beta -galactosidase activities were measured for aerobic cultures of parent and slyA mutant strains. The results indicated that omp expression was activated by SlyA (198 ± 11 Miller units for the parental strain and 110 ± 4 Miller units for the slyA mutant). As observed with the PslyA::lacZ fusion, the presence of SlyA had only a small effect on expression suggesting that under the test conditions SlyA is mostly in an inactive state. Nevertheless the simplest interpretation of the data is that the predicted SlyA site located upstream of the omp coding region is functional in vivo.

The phenotypic tests described here indicated that SlyA is directly or indirectly involved in the regulation fliC, iroN, pagC, and ompC. The available DNA sequences upstream of these coding regions all contained plausible SlyA binding sites (at least 8/12 matches to the consensus) suggesting that SlyA directly regulates these genes. Interestingly, the OmpC protein has been shown to mediate adherence to macrophages (25) and thus provides a link to the impaired ability of the slyA strain to associate with macrophages (Fig. 1). As it is well established that Salmonella thrives within the intracellular environment, entering macrophages in numbers is a virulence determinant for the bacterium, and from the data presented here it would appear that the slyA mutant is impaired in this respect.

The isolation of the SlyA protein and the definition of its target DNA sequence provide solid foundations for further investigation into the nature of the environmental signals perceived and the network of genes regulated by this important transcription and virulence factor. A variety of strategies have been adopted to obtain a comprehensive picture of Salmonella genes required for intracellular growth and survival, including signature tagged mutagenesis, in vivo expression technology, and selective capture of transcribed sequences, but such approaches rarely identify the same genes, suggesting that several approaches will be needed to obtain such a picture. A useful addition is now provided by definition of the DNA sequence recognized by SlyA, a transcription factor essential for intracellular survival. Upon complete annotation of the Salmonella genome sequence it should be possible to interrogate the data base with the SlyA site for close matches within promoter regions. Such investigations will provide new insight into the mechanisms used by the intracellular pathogen S. typhimurium to evade host defenses and cause disease by unambiguously identifying genes important for survival within macrophages.

    ACKNOWLEDGEMENTS

We gratefully acknowledge A. J. G. Moir for DNA and protein sequencing, T. S. Wallis for the slyA mutant strain, S. Thorpe for electrospray ionization mass spectrometry, A. G. Cox for ICP-MS, M. Lee and A. Cook for excellent technical assistance in preparing macrophages, and the Biotechnology and Biological Sciences Research Council UK for financial support with the award of Project Grant BFP11284 and a research studentship.

    FOOTNOTES

* The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

To whom correspondence should be addressed. Tel.: 44-114-2224403; Fax: 44-114-2728697; E-mail: jeff.green@sheffield.ac.uk.

Published, JBC Papers in Press, March 6, 2002, DOI 10.1074/jbc.M110178200

    ABBREVIATIONS

The abbreviations used are: DMEM, Dulbecco's modified Eagle's medium; PBS, phosphate-buffered saline; DAPI, 4,6-diamidino-2-phenylindole dihydrochloride; GST, glutathione S-transferase; IPTG, isopropyl-1-thio-beta -d-galactopyranoside; ICP-MS, inductively coupled plasma mass-spectrometry; RNAP, RNA polymerase.

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

1. Miller, P. F., and Sulavik, M. C. (1996) Mol. Microbiol. 21, 441-448[CrossRef][Medline] [Order article via Infotrieve]
2. Revell, P. A., and Miller, V. L. (2000) Mol. Microbiol. 35, 677-685[CrossRef][Medline] [Order article via Infotrieve]
3. Nagel, G., Lahrz, A., and Dersch, P. (2001) Mol. Microbiol. 41, 1249-1269[CrossRef][Medline] [Order article via Infotrieve]
4. Libby, S. J., Goebel, W., Ludwig, A., Buchmeier, N., Bowe, F., Fang, F. C., Guiney, D. G., Songer, J. G., and Heffron, F. (1994) Proc. Natl. Acad. Sci. U. S. A. 91, 489-493[Abstract/Free Full Text]
5. Daniels, J. J. D., Autenrieth, I. B., Ludwig, A., and Goebel, W. (1996) Infect. Immun. 64, 5075-5084[Abstract]
6. Buchmeier, N., Bossie, S., Chen, C., Fang, F. C., Guiney, D. G., and Libby, S. (1997) Infect. Immun. 65, 3725-3730[Abstract]
7. Wallace, A. J., Stillman, T. J., Atkins, A., Jamieson, S. J., Bullough, P. A., Green, J., and Artymiuk, P. J. (2000) Cell 100, 265-276[CrossRef][Medline] [Order article via Infotrieve]
8. Ludwig, A., Tengel, C., Bauer, S., Bubert, A., Benz, R., Mollenkopf, H., and Goebel, W. (1995) Mol. Gen. Genet. 249, 474-486[CrossRef][Medline] [Order article via Infotrieve]
9. Oscarsson, J., Mizunoe, Y., Uhlin, B. E., and Haydon, D. J. (1996) Mol. Microbiol. 20, 191-199[Medline] [Order article via Infotrieve]
10. Green, J., and Baldwin, M. (1997) Microbiology 143, 3785-3793[Abstract]
11. del Castillo, F. J., Leal, S. C., Moreno, F., and del Castillo, I. (1997) Mol. Microbiol. 25, 107-115[CrossRef][Medline] [Order article via Infotrieve]
12. Ludwig, A., Bauer, S., Benz, R., Bergmann, B., and Goebel, W. (1999) Mol. Microbiol. 31, 557-567[CrossRef][Medline] [Order article via Infotrieve]
13. Miller, J. H. (1972) Experiments in Molecular Genetics , Cold Spring Harbor Laboratory Press, Plainview, NY
14. Sambrook, J., Fritsch, E. F., and Maniatis, T. (1989) Molecular Cloning: A Laboratory Manual , 2nd Ed. , Cold Spring Harbor Laboratory Press, Plainview, NY
15. Guan, K., and Dixon, J. E. (1991) Anal. Biochem. 192, 262-267[CrossRef][Medline] [Order article via Infotrieve]
16. Maxam, A. M., and Gilbert, W. (1980) Methods Enzymol. 65, 499-560[Medline] [Order article via Infotrieve]
17. Aiba, H., Adhya, S., and Decrombrugge, B. (1981) J. Biol. Chem. 256, 1905-1910
18. Gerischer, V., and Durre, P. (1992) J. Bacteriol. 174, 426-433[Abstract/Free Full Text]
19. Baumler, A. J., Kusters, J. G., Stojiljkovic, I., and Heffron, F. (1994) Infect. Immun. 62, 1623-1630[Abstract/Free Full Text]
20. Diagle, F., Graham, J. E., and Curtiss III, R. (2001) Mol. Microbiol. 41, 1211-1222[CrossRef][Medline] [Order article via Infotrieve]
21. Kawakami, T., Kaneko, A., Okada, N., Imajoh-Ohmi, S., Nonaka, T., Matsui, H., Kawahara, K., and Danbara, H. (1999) Microbiol. Immunol. 43, 351-357[Medline] [Order article via Infotrieve]
22. Alekshun, M. N., Levy, S. B., Mealy, T. R., Seaton, B. A., and Head, J. F. (2001) Nat. Struct. Biol. 8, 710-714[CrossRef][Medline] [Order article via Infotrieve]
23. Martin, R. G., and Rosner, J. L. (1995) Proc. Natl. Acad. Sci. U. S. A. 92, 5456-5460[Abstract/Free Full Text]
24. Alekshun, M. N., Kim, Y. S., and Levy, S. B. (2000) Mol. Microbiol. 35, 1394-1404[CrossRef][Medline] [Order article via Infotrieve]
25. Negm, R. S., and Pistole, T. G. (1999) Can. J. Microbiol. 45, 658-669[CrossRef][Medline] [Order article via Infotrieve]
26. Silhavy, T. J., Barman, M. L., and Enquist, L. W. (1984) Experiments with Gene Fusions. , Cold Spring Harbor Laboratory Press, Plainview, NY
27. Lodge, J., Williams, R., Bell, A., Chan, B., and Busby, S. (1990) FEMS Microbiol. Lett. 67, 221-225[CrossRef]
28. Wing, H. J., Williams, S. M., and Busby, S. J. W. (1995) J. Bacteriol. 177, 6704-6710[Abstract/Free Full Text]


Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
H. Song, W. Kong, N. Weatherspoon, G. Qin, W. Tyler, J. Turk, R. Curtiss III, and Y. Shi
Modulation of the Regulatory Activity of Bacterial Two-component Systems by SlyA
J. Biol. Chem., October 17, 2008; 283(42): 28158 - 28168.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
A. A. Larrea, I. M. Pedroso, A. Malhotra, and R. S. Myers
Identification of two conserved aspartic acid residues required for DNA digestion by a novel thermophilic Exonuclease VII in Thermotoga maritima
Nucleic Acids Res., October 1, 2008; 36(18): 5992 - 6003.
[Abstract] [Full Text] [PDF]


Home page
MicrobiologyHome page
D. M. Stoebel, A. Free, and C. J. Dorman
Anti-silencing: overcoming H-NS-mediated repression of transcription in Gram-negative enteric bacteria
Microbiology, September 1, 2008; 154(9): 2533 - 2545.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. C. Perez, T. Latifi, and E. A. Groisman
Overcoming H-NS-mediated Transcriptional Silencing of Horizontally Acquired G